Hepatic artery dissection in a patient on bevacizumab resulting in pseudoaneurysm formation.
Interventional radiologists are frequently encountering patients with colorectal cancer that are being treated with bevacizumab. This therapeutic agent is associated with a potentially increased risk of adverse events when invasive procedures are performed while patients are on therapy. The current case report reviews a complication related to planning angiography for radioembolization with Yttrium-90 microspheres in an individual on bevacizumab and subsequent management of the patient.
Division of Interventional Radiology and the Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Daniel B
DB
Brown